71 research outputs found
Advanced material against human (Including Covidâ19) and plant viruses: nanoparticles as a feasible strategy
The SARSâCoVâ2 virus outbreak revealed that these nanoâpathogens have the ability to rapidly change lives. Undoubtedly, SARSâCoVâ2 as well as other viruses can cause important global impacts, affecting public health, as well as, socioeconomic development. But viruses are not only a public health concern, they are also a problem in agriculture. The current treatments are often ineffective, are prone to develop resistance, or cause considerable adverse side effects. The use of nanotechnology has played an important role to combat viral diseases. In this review three main aspects are in focus: first, the potential use of nanoparticles as carriers for drug delivery. Second, its use for treatments of some human viral diseases, and third, its application as antivirals in plants. With these three themes, the aim is to give to readers an overview of the progress in this promising area of biotechnology during the 2017â2020 period, and to provide a glance at how tangible is the effectiveness of nanotechnology against viruses. Future prospects are also discussed. It is hoped that this review can be a contribution to general knowledge for both specialized and nonâspecialized readers, allowing a better knowledge of this interesting topic.REDESâANID. Grant Number: 180003
Universidad de La Frontera. Grant Number: DI20â1003
FAPESP. Grant Numbers: 2018/08194â2, 2018/02832â7
CNPq. Grant Numbers: 404815/2018â9, 313117/2019â5
CONICYT/FAPESP. Grant Number: 2018/08194â2
Coordenação de Aperfeiçoamento de Pessoal de NĂvel Superior. Grant Numbers: 001, ANID/FONDAP/15130015
FCT. Grant Number: PTDC/CTMâTEX/28295/2017
FEDER
POCI
Portugal 2020 program
COMPETE. Grant Number: UID/CTM/00264/2019
FCT/MCTE
Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögrenâs syndrome
Dengue: a continuing global threat.
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are âŒ50 million dengue infections and âŒ500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future
Estudo imunolĂłgico da esquistossomose mansoni intestinal antes e apĂłs tratamento com aminonitrotiazol
Self-Care, Sense Of Coherence And Depression In Patients Hospitalized For Decompensated Heart Failure
Anthropometric midarm measurements can detect systemic fat-free mass depletion in patients with chronic obstructive pulmonary disease
- âŠ